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Summary  
Background: Currently UK vCJD cases total 178, with an estimated maximum 1:2,000 
carriage rate based on archived appendix and tonsil tissue, implying infection maybe rare but 
carriage relatively common. Previous workers have identified that maintenance of surgical 
instruments in a humid atmosphere after use and prior to cleaning assists cleaning efficacy. 
Relatively recently the Department of Health/Advisory Committee on Dangerous Pathogens 
UK have recommended a surgical instrument cleanliness threshold post cleaning of <5µg 
protein per instrument side. 
Aim: Quantitate cleanliness of neurosurgical instruments and investigate cost-effective 
measures for improved cleaning. 
Methods: Two instrument protein quantitation methods were used. One based on the 
International Standard (15883 series) using sodium dodecyl sulphate (SDS) elution and 
orthophthalaldehyde (OPA) reaction and a second in-situ protein fluorescence detection 
system (ProReveal) providing results per instrument side.  In vitro investigation of the 
efficacy of some commercial and in-house pre-clean wetting agents was undertaken using 
artificial test soil and stainless steel discs under standard conditions. In vivo evaluation of 
best performing in vitro agents was undertaken on craniotomy sets. 
Findings: Residual protein levels using ProReveal technology demonstrated that 163/187 
(87%) of neurosurgical instruments were <5µg protein/instrument side. The use of 
proprietary NHS plastic bags and sterile water soaked wound pads were equivalent in 
efficacy to commercial pre-cleaning wetting products and significantly less expensive. 
Conclusion: Although we demonstrate low in situ protein levels on neurosurgical 
instruments and the beneficial effects of keeping instruments moist, other cleaning critical 
control points such as instrument loading patterns should also be monitored. 
 
 
 
Key words: CJD, pre-cleaning, cleaning, risk reduction, neurosurgical instruments, 
automated washer-disinfector.   
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Introduction 
Although most of the UK population was exposed to BSE largely between the early 1980’s – 
mid 1990’s, symptomatic cases of vCJD have remained rare.  There have been 178 cases in 
the UK (1) and in terms of iatrogenic CJD linked to medical devices there have been six 
instances reported Worldwide (2). However, results of three major appendix surveys carried 
out to date all show prevalence of abnormal prion protein in the UK population to be around 
1 in 2,000 – 1 in 5,000 (3-5). Implying infection maybe rare but carriage relatively common.  
Prions are very difficult to inactivate and infectivity can survive steam sterilization at 
134°C(6).  With variant CJD (vCJD), there are particular concerns about potential spread 
from central nervous system (CNS) and lymphatic tissue. Within Scotland steps have been 
taken to reduce the risks of vCJD transmission by improving the decontamination of re-
usable surgical instruments (7-9). Risk assessments have emphasized the importance of 
cleaning surgical instruments prior to sterilization and high carriage rates emphasise the 
continued role of risk reduction strategies (5,10). Previous workers have demonstrated the 
importance of maintaining surgical instruments in a moist state prior to loading into a wash 
process (11,12). 
The aim of this study was to investigate processes to improve the cleaning of neurosurgical 
instruments by quantitating residual protein levels on washed instruments, which pre-
cleaning treatment methods are efficacious and cost- effective and whether quantitative 
protein estimation methods can be used to quality control neurosurgical instrument cleaning. 
 
Methods 
Neurosurgical instruments and set selection 
The 5 most commonly used sets of neurosurgical instruments in NHS Greater Glasgow & 
Clyde and the 5 most common supplementary items were selected for study. Within each set 
the project group agreed to assay a minimum of 5 different instruments that were most 
frequently used during an operation linked to a specific set of instruments. Frequency of use 
based on clinical experience of the project group Neurosurgeon (NS) and Neurology Theatre 
Co-ordinator (PP). Details of sets, instruments and supplementals are summarised in 
supplemental Table Ia & Ib, where opportunity arose additional instruments were included. 
Assays for residual protein levels were undertaken on used instruments prior to cleaning and 
following cleaning in an automated washer disinfector. 
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Neurosurgical theatre instrument preparation following use, transportation and wash 
process. 
During use neurosurgical instruments are manually wiped clean as per theatre standard 
operating practice. On completion of the operation and determination of set integrity, trays 
are wrapped in a proprietary NHS clear plastic bag and placed in a wheeled buggy for uplift 
and transport to the Sterile Service Department (SSD), Cowlairs. In the Wash room at the 
SSD instruments are removed from the theatre tray and loaded into washer baskets and 
placed in the automated washer disinfector (AWD) (Supplemental figure 1). 
The automated washer disinfector (AWD) used throughout this study was a Getinge model 
CM310 using detergent Metal Clean (pH 13.1). The instruments are exposed to 4 phases of 
an automated wash process in 4 different chambers. Chamber 1: prewash with mains water at 
30ºC for 8 minutes, wash with mains water at 55ºC for 10 minutes with 6ml detergent/1 litre 
of mains water followed by chamber 2: Mains water rinse for 5 minutes followed by reverse 
osmosis (RO) water rinse at 90ºC for 1 minute followed by chambers 3 and 4 hot air drying 
for 15 minutes each. Total cycle time (including heat up and cool down is 55 minutes). Each 
AWD undergoes an annual performance qualification test using a standard load, soiled with 
Edinburgh test soil and cleaning efficacy assessed visually and swabbing with a protein 
detection swab (3M protein trace). 
 
Protein assays 
SDS extraction and Orthophthaladehyde (OPA) method  
This method was based on that described in the ISO 15883 standard (13-15) and previous 
workers (16,17). Briefly, the instrument was placed in a polythene bag and after addition of 5 
or 10ml (depending on size of instrument) of 1% Sodium Dodecyl Sulphate (SDS), the bag 
was agitated by hand over a period of 30 mins to ensure that the SDS solution was able to 
access all surfaces. Aliquots of eluent were assayed using OPA solution in triplicate. A 
bovine serum albumin (BSA, Sigma) standard curve and blank controls were run with each 
assay. The limit of detection was 3µg protein/ml (30 µg protein/instrument if 10ml elution 
volume used). 
 
In-situ analysis of residual protein using OPA (ProReveal) 
This method was based on the manufacturer’s instructions (Synoptics Ltd, Cambridge) for 
the ProReveal technology (GBox EF2 with ProReveal software). The ProReveal test consists 
of a reagent based on an OPA fluorescent spray, which reacts with protein residues left on 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 5
instruments without the requirement for an elution stage (18). A similar number of replicates 
was undertaken using the ProReveal system to quantitate and locate residues of protein on 
instruments. Calibration of the ProReveal equipment was undertaken using BSA standard 
curves. The limit of detection was 50ng protein/cm2 instrument surface. For both assays, sets 
of new unused surgical scissors but cleaned using the same AWD process was used as a 
negative control.  
 
In vitro assessment of pre-cleaning solutions 
This was undertaken by applying Edinburgh Test Soil (made-up in house according to 
specification in TS/ISO 15883-5 (15)) to stainless steel discs. 10 µl of Edinburgh test soil 
(3.4 µg protein) were applied to 24 stainless steel (316 stainless steel, mirror finish) discs (1 
cm diameter) in a 24 well plate (Costar, ThermoScientific) and allowed to air dry overnight. 
This stage was introduced to provide a worse case scenario for soil drying onto instruments 
during prolonged theatre cases. The plate was then transferred into a sealable bag (zip-lock, 
Tesco, UK) and the “wetting agent” was applied according to manufacturer’s instructions and 
left for 80 min (time determined as worst case scenario for period during which “wetting 
agent” would be in contact with instruments from preliminary studies). This was followed by 
a standardized washing step on a motorized rocking platform (Grant Bio PMR 32 Rocker set 
at 20 tilts per minute at room temperature). Each well containing a soiled disc was then 
exposed to 2 ml of 1% SDS for 5 minutes (time exposure based on validation work using 
different time points, data not shown) following which the disc was removed and residual 
protein levels assayed using ProReveal technology. Each test condition was undertaken with 
x3 discs and assayed in triplicate. A “bag control” with soiled discs in a plastic bag without 
wetting agent as well as a control without bag or wetting agent was included for each 
experiment.  
 
Pre-cleaning solutions investigated 
Preliminary investigations (data not shown) had demonstrated that equivalent humidity levels 
were obtained in standard NHS plastics bags compared to commercially available plastic 
bags. The NHS bags were used subsequently for all further experiments. The wetting agents 
assessed included Prepzyme (Ruhoff Corporation, 393 Sagamore Avenue, Mineola, NY, 
USA), Foreverwet (Ruhof), Pre-Klenz transport gel (Steris Corporation 5960 Heisley Road, 
Mentor, OH, USA), Neozyme (Medimark Scientific Ltd, P. O. Box 573, Sevenoaks, Kent 
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TN13 9RQ, United Kingdom) and sterile water on an absorbent pad (NHS wound pads - 
40x20cms).  
 
 
In vivo assessment of best performing pre-cleaning solutions 
The best performing wetting agents from the in-vitro study i.e., Steris Pre-Klenz and sterile 
water/pad plus the proprietary NHS theatres clear plastic bag (610x760mm) were 
investigated in-vivo as part of a clinical trial of different wetting agents. For the purposes of 
the trial, the most frequently used set (Craniotomy set) was investigated, from which the 
Adsons elevator was selected as a process challenge instrument coated with Edinburgh test 
soil (15).  
Efficacy of pre-cleaning solutions was assessed using two different soiling methods; a. 
Native soil: Instruments from craniotomy sets were assayed for residual protein after use and 
exposed to either Steris Pre-Klenz wetting agent or sterile water/pad both enclosed using the 
same NHS proprietary clear plastic bag. b. Artificially soiled difficult to clean instruments: 
Two process challenge instruments (Adson elevators) were added to each craniotomy set 
after soiling with Edinburgh Test soil. The duration of drying of Edinburgh test soil was 
based on data derived from instrument set waiting times between theatre operation 
completion and wash process at Cowlairs SSD. The artificially soiled Adson elevators were 
added to craniotomy sets (in duplicate) at the SSD wash-room and loaded into the AWD 
alongside the instruments with native soil. These acted as “indicator” instruments to assess 
the feasibility of using a process challenge instrument from a nominated instrument set to 
provide an indicator of cleanliness without holding back the progress of the set through the 
decontamination process. Following use in theatres, a craniotomy set was prepared for 
transportation using the wetting agent. Each wetting agent was applied for a consecutive 
series of 10 trays. On arrival in the SSD the tray was identified and the “indicator” 
instruments included in the same wash basket as the craniotomy set. Following the wash 
process the craniotomy instruments were assayed using the in-situ OPA assay for residual 
protein content as previously described. 
Estimate of instrument surface area  
In order, to capture surface area data from our study instruments we developed a method to 
calculate the 2-D surface area of the instruments we have assayed by photographing, 
digitalizing and outlining the area of the instrument. All instruments were imaged using a 
digital camera positioned analogously to their position during protein-detection test using 
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ProReveal against a scale (cm). Software (ImageJ ver. 1.8) was used to trace the edges of 
each instrument and the outlined area measured to provide an approximate instrument surface 
area in cm2. 
 
Statistical analysis 
SPSS statistics software (IBM, Chicago USA) was used for statistical analyses. For research 
question “which pre-cleaning treatment methods are most efficacious”, the in-vitro data was 
plotted in Microsoft Excel, to compare performance based on residual protein levels and 
analysis was performed on log-transformed data using ANOVA and a Tukey post-test. For 
research question “which pre-cleaning treatment methods are most efficacious”,  the in vivo 
results of cleaned instruments without pre-treatment were compared with results after pre-
treatment 1 (Steris PreKlenz) and pre-treatment 2 (Sterile water), using log transformed data 
and ANOVA and Tukey post-test. 
 
Results 
Quantitative analysis of protein residues on neurosurgical instruments 
During the course of this investigation we assayed over a 1,000 neurosurgical instruments, 
the breakdown of instruments assayed (excluding periosteal elevators) is summarised in 
Supplemental Table II. An example of residual protein detected on a McKissock Dural 
scissors is shown in Supplemental Figure 2. Details of protein levels on instruments from the 
different neurosurgical sets are found in Supplemental Tables III-XIV. The distribution of 
individual instrument protein levels using the ProReveal method is summarised in Figure 1.  
In-vitro residual protein level results for all wetting agents tested and controls were assayed 
after 5 minutes cleaning under standard conditions (rocking platform and 1% SDS solution at 
room temperature). Results are summarised in Table 1. Steris Pre-Klenz and Sterile Water 
show significantly cleaner results (p<0.001) when compared to discs with no bag and no 
wetting agent.  
 
In-vivo results 
There were two arms to this investigation that determined the effect of the Steris wetting 
agent or sterile water/pad on cleaning efficacy. Each wetting agent was tested on 10 
consecutive craniotomy trays. From each tray, eight different instruments were assayed for 
residual native soil. In addition, each tray processed had two artificially soiled Adson 
elevators, included to test the efficacy of the wash process. For both the Steris wetting agent 
and sterile water pretreated instruments the residual protein on instruments was below the 
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limit of detection for the OPA assay (30 µg/instrument) this was significantly lower 
(p<0.0001) than that for the untreated craniotomy sets (Supplemental table XV). The addition 
of the elevator instrument artificially soiled with Edinburgh test soil as a process challenge 
device also proved a useful addition to each set and residual soil levels were below the limit 
of detection for this challenge.  Residual protein levels were significantly lower after cleaning 
of wetting agent pre-treated instruments. There was no significant difference between the 
wetting agents Steris Pre-Klenz and sterile water/pad methods. In terms of administrative 
logistics from a theatre and SSD perspective no adverse issues, such as instrument corrosion, 
were identified with either of the trialed pre-cleaning solutions. 
 
Costings 
Details of background information linked to costings of different components for the pre-
cleaning agents is summarized in Supplemental Tables XVI-XVIII. In summary (and 
assuming products used for the 7,355 neurosurgical trays reprocessed annually at Cowlairs 
SSD), the equivalent NHS bags could produce a cost saving of 91% (£7,355 versus £440). 
The trial using sterile water and wound pads produced a 25% saving (£956) per annum. 
Further cost savings can be made using tap water and tray liner producing an 89% saving 
(£3,457 pa).  
 
Optimising the cleaning process 
Using the in-situ protein assay (ProReveal) the combination of the numbers of cleaned 
instruments versus the remaining protein per instrument side following cleaning is 
summarized in Figure 2. These results demonstrated that 163/187 (87%) met a cleanliness 
threshold criteria [19,20] of <5 µg protein/instrument side and 179/187 (96%) were less than 
10 µg protein/instrument side. Analysis of instrument surface area versus residual protein on 
cleaned instruments is summarised in Figure 3.  
Investigation into patterns of residual protein levels of those instruments that crossed a 20 µg 
protein instrument threshold could not identify consistent patterns (ineffective washer run, 
design of instrument or surface area for example) during the wash process that could account 
for these differences. However, an incidental finding linked to opportunistic sampling of a set 
of periosteal elevators highlighted a potential confounding factor in the cleaning process 
(Supplemental figures 3,4). The periosteal elevators, with a flat and easy to clean surface had 
surprisingly high residual protein levels ranging from 34-451 µg /instrument whilst other 
instruments from the same set had significantly lower levels. This finding prompted 
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investigation into the loading patterns of neurosurgical sets, which noted that there was no 
standard protocol for loading sets of instruments into the washing basket leading to a risk of 
“shadowing” and subsequent impaired cleaning of instruments (Supplemental figure 1). 
Misloading of sets into washing baskets was a random process leading to the pattern of 
residual protein noted on instruments.  Reproduction of the detailed loading pattern used 
during the performance qualification testing where cleaning efficacy was established is 
essential for each washer run for reproducible cleaning outcomes. It should also be apparent 
that the test load used during performance qualification should ideally be representative of a 
neurosurgical set (ref to SHTM 2030 new ref 21). Until issues surrounding the loading 
patterns of instruments in wash baskets could be resolved further work on use of statistical 
process control methodology could not be advanced as part of this project. 
 
Discussion 
Previous workers have demonstrated the importance of maintaining surgical instruments in a 
moist state prior to loading into a washer disinfector (11,12,20). Replication of this 
fundamental principle was not the aim of this project, rather we provide quantitative data on 
cleaning efficacy and equivalence of more cost effective measures for improving cleaning 
that could be widely adopted and aid in risk reduction from iatrogenic CJD transmission. The 
use of two different protein detection approaches provides a unique in-sight into the efficacy 
of the cleaning process at a large SSD. 
Previous studies (17,22) have reported residual contaminants on instruments assayed from a 
variety of SSD’s in the UK. This earlier quantitative work on protein residues is a useful 
benchmark from which to judge the effectiveness of multiple improvement changes in SSD 
decontamination processes in Scotland (8,9). Findings from these earlier studies indicated 
protein residues up to 2.2 mg protein instrument (range of medians reported 8-91 µg 
protein/instrument) and using an energy dispersive x-ray analysis (22) assay 120 surgical 
instruments from a range of specialties had a range of medians from 267-756 µg 
protein/instrument set. It is of interest to note that these earlier reports assayed instruments 
following the steam sterilization process, whether this additional step exposing residual 
protein to steam at 134°C increases or decreases estimates of residual protein is unknown. 
Furthermore, no details were presented on the validation of the washers or the wash 
cycle/detergent combinations to which the instruments were exposed. The work reported here 
using the SDS elution and OPA quantitation methodology is similar to one of the earlier 
studies (17) and also using techniques with a higher resolution have confirmed that routinely 
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reprocessed neurosurgical instruments using the cleaning processes in Cowlairs SSD have 
significantly lower residues of protein detected. We extend further knowledge by placing 
these results into the context of the washer cycle used for reprocessing. 
Analysis of residual protein levels using ProReveal technology and reference to the recent 
ACDP recommendations of <5 µg protein/instrument side (19) demonstrated that 163/187 
(87%) met this criteria and 179/187 (96%) were less than 10µg protein/instrument side. In the 
context of the ACDP proposal (19) that a " lower level is necessary for neurosurgical 
instruments"   but remains unspecified we show in Figure 2 that 122 instruments (65%) 
would be ≤2µg of residual protein per instrument side. However, the rationale for a lower 
limit for neurosurgical instruments (or indeed the 5µg limit) is unclear. In terms of protein 
levels/cm2 instrument surface all instruments were below the proposed new International 
standard (23) surgical instrument clean threshold of 6.4ug/cm2. With reference to the SDS 
elution and OPA analysis results mapped against the RKI (German) (24) standard cleanliness 
threshold of <100ug/instrument there were 347/351 (99%) cleaned instruments that met this 
criteria.   
A number of previous studies (11,12)  and UK (England) guidance (20) have identified the 
importance of maintaining a moist environment around used surgical instruments prior to 
cleaning. This has led to the marketing of a wide variety of  pre-cleaning “wetting” agents 
designed with this objective in mind. There have been anecdotal reports of problems caused 
by some of these agents such as, excessive foaming during the wash stage leading to washer 
pump problems and residues remaining after drying out of the wetting agent. In addition, 
with a typical SSD using several thousands of tray sets per year there is a significant cost 
implication. The cost of the preferred NHS method (using “NHS” plastic bags plus wound 
pad plus sterile water) produced significant cost savings that could be further improved by 
the use of tap water and tray liners. An interesting confounding variable came to light during 
the course of the study whereby three instruments (periosteal elevators) with simple, flat and 
smooth surfaces recorded high protein levels post cleaning that could not be explained by 
their simple easy to clean construction. We suspect that these devices had been incorrectly 
loaded into the washer baskets, further confounding efforts to rationalise cleaning 
improvements for neurosurgical instruments.   
In conclusion, we present quantitative data on residual protein levels on neurosurgical 
instruments post washing to provide an in-sight into compliance with recent guidance on 
thresholds designed to reduce the risks for iatrogenic disease transmission linked to vCJD. 
We demonstrate that 163/187 (87%) of neurosurgical instruments were <5µg 
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protein/instrument side. Loading patterns of instruments into the washer disinfector is a 
critical control point which should be optimised and reproduced at subsequent loadings prior 
to wide spread introduction of quantitative residue technologies on cleaned instruments. We 
also demonstrate that relatively simple and inexpensive measures can lead to significant 
improvements in the cleaning of neurosurgical instruments.  
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 Table 1 Residual protein levels of soiled discs with or without a range of pre-cleaning agents and 
followed by 5 minutes wash (ProReveal analysis) 
 
 No bag/no wetting 
agent 
Bag/no 
wetting agent 
Bag/H2O as 
wetting agent  
Bag/Steris Pre-
Klenz 
Bag/Ebiox 
Neozyme 
Bag/ 
Ruhof 
Prep- 
zyme 
Bag/ 
Ruhof 
Forever wet 
Mean (ug 
protein /disc) 171 49 21 21 48 33 40 
Median 
(ug protein 
/disc) 122 52 15* 7* 14 31 39 
SD 114 27 11 24 61 11 22 
Range 
(ug protein 
/disc) 51-379 15-89 11-43 3-68 4-172 11-49 14-76 
 
(*P<0.001 compared to no bag and no pre-cleaning agent) 
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